New ASH guidelines: VTE prevention and treatment in cancer patientsMarch 2, 2021ThrombosisPreventive CarePatient & Survivor CareVenous ThromboembolismHematologyOncology
Large study finds trans men on testosterone at risk for blood clotsFebruary 22, 2021Transgender HealthThrombosisMen's HealthEndocrinology
FDA alert confirms heart and cancer risks with tofacitinib (Xeljanz)February 5, 2021Rheumatoid ArthritisPsoriatic ArthritisPediatricsRheumatologyGastroenterologyPulmonologyThrombosis
Microthrombi, necrosis seen in COVID-19 hearts on autopsyFebruary 3, 2021ThrombosisCOVID-19 UpdatesCAD & AtherosclerosisCardiologyPulmonologyInfectious DiseasesInterventional Cardiology & Surgery
Full-dose anticoagulation reduces need for life support in COVID-19January 25, 2021COVID-19 UpdatesCardiologyThrombosisHematologyInterventional Cardiology & Surgery
In COVID-19 patients, risk of bleeding rivals risk of thromboembolismJanuary 12, 2021ThrombosisCardiologyCOVID-19 UpdatesHematologyBleeding Disorders
A 4-point thrombocytopenia score was found able to rule out suspected HITJanuary 11, 2021Bleeding DisordersThrombosisHematologyPreventive Care
DOACs look safe in elective endoscopic proceduresDecember 31, 2020GastroenterologyHematologyThrombosisEndoscopyGastrointestinal Cancer
NETs a possible therapeutic target for COVID-19 thrombosis?December 31, 2020COVID-19 UpdatesThrombosisCardiology
COVID-19 anticoagulation trials ‘paused’ for futility, safetyDecember 22, 2020COVID-19 UpdatesThrombosis
ASH guidelines for venous thromboembolism: What family physicians need to knowDecember 22, 2020HematologyPulmonologyCardiologyVenous ThromboembolismThrombosis
COVID-19 and risk of clotting: ‘Be proactive about prevention’December 8, 2020ThrombosisCOVID-19 UpdatesArrhythmias & EPHeart FailureCardiologyStrokePulmonology
Cost is the main hurdle to broad use of caplacizumab for TTPDecember 7, 2020ThrombosisBleeding DisordersHematology
No benefit from tranexamic acid prophylaxis in blood cancersDecember 7, 2020ThrombosisPatient & Survivor CareBleeding Disorders
VTE prophylaxis is feasible, effective in some high-risk cancer patientsDecember 4, 2020ThrombosisPatient & Survivor CareHematologyVenous Thromboembolism